Ab initio quantum mechanical study of the binding energies of human estrogen receptor α with its ligands: An application of fragment molecular orbital method

We have theoretically examined the relative binding affinities (RBA) of typical ligands, 17β‐estradiol (EST), 17α‐estradiol (ESTA), genistein (GEN), raloxifene (RAL), 4‐hydroxytamoxifen (OHT), tamoxifen (TAM), clomifene (CLO), 4‐hydroxyclomifene (OHC), diethylstilbestrol (DES), bisphenol A (BISA), and bisphenol F (BISF), to the α‐subtype of the human estrogen receptor ligand‐binding domain (hERα LBD), by calculating their binding energies. The ab initio fragment molecular orbital (FMO) method, which we have recently proposed for the calculations of macromolecules such as proteins, was applied at the HF/STO‐3G level. The receptor protein was primarily modeled by 50 amino acid residues surrounding the ligand. The number of atoms in these model complexes is about 850, including hydrogen atoms. For the complexes with EST, RAL, OHT, and DES, the binding energies were calculated again with the entire ERαLBD consisting of 241 residues or about 4000 atoms. No significant difference was found in the calculated binding energies between the model and the real protein complexes. This indicates that the binding between the protein and its ligands is well characterized by the model protein with the 50 residues. The calculated binding energies relative to EST were very well correlated with the experimental RBA (the correlation coefficient r = 0.837) for the ligands studied in this work. We also found that the charge transfer between ER and ligands is significant on ER–ligand binding. To our knowledge, this is the first achievement of ab initio quantum mechanical calculations of large molecules such as the entire ERαLBD protein. © 2004 Wiley Periodicals, Inc. J Comput Chem 26: 1–10, 2005

[1]  Kaori Fukuzawa,et al.  Fragment molecular orbital method: use of approximate electrostatic potential , 2002 .

[2]  H Fang,et al.  Quantitative comparisons of in vitro assays for estrogenic activities. , 2000, Environmental health perspectives.

[3]  C. Glass,et al.  The coregulator exchange in transcriptional functions of nuclear receptors. , 2000, Genes & development.

[4]  Gerald T. Ankley,et al.  The role of ligand flexibility in predicting biological activity: Structure–activity relationships for aryl hydrocarbon, estrogen, and androgen receptor binding affinity , 1998 .

[5]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[6]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Corton,et al.  Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β. , 1998, Endocrinology.

[8]  Gustavo E. Scuseria,et al.  Linear Scaling Density Functional Calculations with Gaussian Orbitals , 1999 .

[9]  J. Gustafsson,et al.  Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. , 1998, Molecular pharmacology.

[10]  J. Gustafsson,et al.  ERβ a Novel Estrogen Receptor Offers the Potential for New Drug Development , 1998, Trends in Endocrinology & Metabolism.

[11]  Ching-Hsing Yu,et al.  Ab Initio Geometry Determinations of Proteins. 1. Crambin , 1998 .

[12]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[13]  Yuto Komeiji,et al.  Fragment molecular orbital method: analytical energy gradients , 2001 .

[14]  P B Sigler,et al.  Crystallographic comparison of the estrogen and progesterone receptor's ligand binding domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Tudor I. Oprea,et al.  Ligand-based identification of environmental estrogens. , 1996, Chemical research in toxicology.

[16]  Fumitoshi Sato,et al.  Calculation of all-electron wavefunction of hemoprotein cytochrome c by density functional theory , 2001 .

[17]  Yutaka Akiyama,et al.  Fragment molecular orbital method: application to polypeptides , 2000 .

[18]  J. Pitera,et al.  Simulations of the estrogen receptor ligand-binding domain: affinity of natural ligands and xenoestrogens. , 2000, Journal of medicinal chemistry.

[19]  J. V. van Lier,et al.  Quantitative structure-activity relationships/comparative molecular field analysis (QSAR/CoMFA) for receptor-binding properties of halogenated estradiol derivatives. , 1994, Journal of medicinal chemistry.

[20]  B. Katzenellenbogen,et al.  Different Residues of the Human Estrogen Receptor Are Involved in the Recognition of Structurally Diverse Estrogens and Antiestrogens* , 1997, The Journal of Biological Chemistry.

[21]  Kaori Fukuzawa,et al.  Fragment molecular orbital study of the binding energy of ligands to the estrogen receptor , 2003 .

[22]  Masami Uebayasi,et al.  Pair interaction molecular orbital method: an approximate computational method for molecular interactions , 1999 .

[23]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.

[24]  K. Kitaura,et al.  Fragment molecular orbital method: an approximate computational method for large molecules , 1999 .

[25]  D. Moras,et al.  Crystal Structure of a Mutant hERα Ligand-binding Domain Reveals Key Structural Features for the Mechanism of Partial Agonism* , 2001, The Journal of Biological Chemistry.

[26]  M Carlquist,et al.  Structure of the ligand‐binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist , 1999, The EMBO journal.

[27]  D. Moras,et al.  Structural studies on nuclear receptors , 2000, Cellular and Molecular Life Sciences CMLS.

[28]  Kenichiro Tsuda,et al.  Ab initio MO studies of interaction mechanisms of Protein Kinase C with cell membranes , 2001 .

[29]  F. Sato,et al.  An all-electron calculation of an antihypertensive protein with the Gaussian-based density functional method , 1999 .

[30]  Marvin Waldman,et al.  Application of structure‐based focusing to the estrogen receptor , 2001, J. Comput. Chem..

[31]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[32]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[33]  Gerald T. Ankley,et al.  Quantitative structure‐activity relationships for polychlorinated hydroxybiphenyl estrogen receptor binding affinity: An Assessment of conformer flexibility , 1996 .

[34]  K. Grandien,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors � and � , 2022 .

[35]  Eric Schwegler,et al.  Linear scaling computation of the Fock matrix , 1997 .

[36]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[37]  Carlos Sonnenschein,et al.  An updated review of environmental estrogen and androgen mimics and antagonists , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[38]  A. Steinmetz,et al.  Binding of ligands and activation of transcription by nuclear receptors. , 2001, Annual review of biophysics and biomolecular structure.

[39]  Roger Perkins,et al.  QSAR Models for Binding of Estrogenic Compounds to Estrogen Receptor α and β Subtypes. , 1997, Endocrinology.